Photo taken from Patrick Hwu/X
Mar 25, 2024, 12:39
Patrick Hwu: This study demonstrates the importance of vaccine route when designing cancer immunotherapies
Patrick Hwu, President and CEO at Moffitt Cancer Center, posted on X/Twitter:
“For cancer vaccines to be effective, they need to generate tumor reactive T cells capable of migrating into tissues. Does vaccine route of administration matter? In this study, investigators found that intranasal (mucosal) vaccination resulted in T cells that were capable of infiltrating lung tissue compared to intramuscular vaccination. The mucosal vaccine decreased lung metastases in a murine breast cancer model. The effects were enhanced when the vaccine also encoded IL-1 beta and combined with radiation. This study demonstrates the importance of vaccine route when designing cancer immunotherapies.
Here’s a link to the full article.”
Source: Patrick Hwu/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14